SEC Form 4 · accession 0001209191-15-064625

TANDEM DIABETES CARE INC · TNDM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP & CHIEF OPERATING OFFICER

Period of report

Aug 5, 2015

Accepted (ET)

Aug 7, 2015 · 4:13 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001438133

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 5, 2015	M	17,500	$1.1059	A	21,584	D
Common Stock^F1	Aug 5, 2015	S	17,500	$12.6965	D	4,084	D
Common Stock	Aug 6, 2015	M	17,500	$1.1059	A	21,584	D
Common Stock^F2	Aug 6, 2015	S	17,500	$12.1942	D	4,084	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options^F3	$1.1059	Aug 5, 2015	M	17,500	D	Feb 25, 2014	Apr 23, 2023	Common Stock	17,500	137,540	D
Stock Options^F3	$1.1059	Aug 6, 2015	M	17,500	D	Feb 25, 2014	Apr 23, 2023	Common Stock	17,500	120,040	D

F1The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $12.50 to $13.05. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F2The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $12.08 to $12.50. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F3The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.